Amgen To Get A Boost From Osteoporosis Drug Study

September 16, 2008

Amgen Inc. is set to showcase positive results from a study on their osteoporosis drug candidate, denosumab.......Boston (ChattahBox) – Amgen Inc. is set to showcase positive results from a study on their osteoporosis drug candidate, denosumab.

Amgen Inc. will unveil the study just after the market opens up on Tuesday, and will showcase how effective the drug is.

The new study three-year, Phase 3 trial which compared denosumab with a placebo.

A separate study released by the company on Monday showed that women who went from Fosamax to denosumab experienced an increase in bone density.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.